Showing results (2361-2370 of 10,003) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|October 6, 2025
The tumor microenvironment in hairy cell leukemia (HCL) and splenic B cell lymphoma with prominent nucleoli (SBLPN)Titus Watrin, Marc Seifert, Sascha Dietrich
Leukemia & Lymphoma|October 14, 2025
Challenges in predicting outcomes for watch and wait follicular lymphoma patients: insights into clinical, pathological, and molecular factorsEva A M Hesius, James P Stewart, Leonie I Kroeze, et al.
Leukemia & Lymphoma|October 16, 2025
First case report of talquetamab use in AL amyloidosisNoa Gross Even-Zohar, Shlomzion Aumann, Adir Shaulov, et al.
Leukemia & Lymphoma|October 6, 2025
Venetoclax plus hypomethylating agents versus priming regimen as the first-line therapy for newly diagnosed acute myeloid leukemia with myelodysplasia-related changes: a propensity score-matched analysisYuan-Hong Huang, Fang-Tong Liu, Chao-Ling Wan, et al.
Leukemia & Lymphoma|September 29, 2025
The risk of second primary malignancies in patients receiving T-cell directed therapies for multiple myeloma: a systematic reviewHyun Park, Julian Robinson, Cliona Flanagan, et al.
Leukemia & Lymphoma|October 3, 2025
Subcutaneous daratumumab plus carfilzomib and dexamethasone (D-Kd) versus carfilzomib and dexamethasone (Kd) in patients with relapsed/refractory multiple myeloma who received previous daratumumab treatment: LYNX studyNizar J Bahlis, Jeffrey Zonder, Lionel Karlin, et al.
Leukemia & Lymphoma|August 19, 2025
Measurable residual disease dynamics holding prognostic significance in pediatric patients with RUNX1::RUNX1T1-positive AML: results from AML-CAMS serial trialsLuyang Zhang, Meihui Yi, Xiaoli Chen, et al.
Leukemia & Lymphoma|August 14, 2025
Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agentsSeda S Tolu, Caitlin Gribbin, Zhengming Chen, et al.
Leukemia & Lymphoma|August 8, 2025
The evolution of treatment for pediatric advanced stage classic Hodgkin lymphoma - a narrative literature reviewNisha Shariff, Foo Jen Chun, Susan K Parsons, et al.
Leukemia & Lymphoma|August 11, 2025
Romidepsin and mogamulizumab sequential treatment for advanced cutaneous T-cell lymphomaEmily R Gordon, Seda Tolu, Brigit A Lapolla, et al.
Pageof 1,001